265 related articles for article (PubMed ID: 15313147)
1. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
2. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
[TBL] [Abstract][Full Text] [Related]
3. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
[TBL] [Abstract][Full Text] [Related]
4. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
6. [The value of serum alpha-L-fucosidase activity in the diagnosis of primary liver cancer].
Wei X; Wang S; Rui J
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):148-50. PubMed ID: 11776645
[TBL] [Abstract][Full Text] [Related]
7. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
Shen W; Shen DM
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
Shi X; Zhou Y; Xia L
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
[TBL] [Abstract][Full Text] [Related]
9. Potentiometric determination of α-L-fucosidase enzyme by using 2-chloro-4-nitrophenol-rhodamine B ion pair chemical recognition in PVC membrane sensor.
Othman AM; El-Houseini ME; El-Sofy MS; Aboul-Enein HY
Anal Bioanal Chem; 2011 May; 400(3):787-95. PubMed ID: 21360032
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma.
Yamamoto K; Yanagita T; Watanabe N; Morito F; Ozaki I; Motomura M; Ikuyama S; Setoguchi Y; Fujii S; Kariya T
Fukuoka Igaku Zasshi; 1988 Jun; 79(6):463-8. PubMed ID: 2852632
[No Abstract] [Full Text] [Related]
11. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
[TBL] [Abstract][Full Text] [Related]
12. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
14. Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Zheng T; Ren ZY
Chin Med J (Engl); 1990 Sep; 103(9):729-34. PubMed ID: 2174763
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma].
Yu ZW; Duan FL; Yang XW
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):394-6, 442. PubMed ID: 2556248
[TBL] [Abstract][Full Text] [Related]
16. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
17. [Value of serum glycosidase spectrum in the diagnosis of hepatocellular carcinoma].
Zhang SM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):143-6. PubMed ID: 1319891
[TBL] [Abstract][Full Text] [Related]
18. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.
Xing H; Qiu H; Ding X; Han J; Li Z; Wu H; Yan C; Li H; Han R; Zhang H; Li C; Wang M; Wu M; Shen F; Zheng Y; Yang T
Biomark Med; 2019 May; 13(7):545-555. PubMed ID: 31140827
[No Abstract] [Full Text] [Related]
19. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
[TBL] [Abstract][Full Text] [Related]
20. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
